4//SEC Filing
Cross John Harry III 4
Accession 0001493152-20-012570
CIK 0001106838other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:17 PM ET
Size
5.1 KB
Accession
0001493152-20-012570
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Award
Common Stock
2020-07-02+78,214→ 78,214 total
Footnotes (1)
- [F1]On July 2, 2020, the Reporting Person was granted 78,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001806763
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:17 PM ET
- Size
- 5.1 KB